Healthcare transformation has been a widely discussed topic for years, with many arguing for a more streamlined and tech- and data-driven approach to the industry that affects all people. As technology has evolved and patient needs have shifted to expect consumer-friendly, digital-enabled healthcare experiences, there’s been an even more forceful push toward personalised, precise, and integrated healthcare models.
Angelini Ventures, the recently launched venture capital arm of Angelini Industries, aims to take on the need for healthcare innovation. The fund, led by managing directors Paolo Di Giorgio, who also serves as CEO, and Elia Stupka, will use its €300 million capital commitment to invest in early-stage and innovative biotechnology, digital health, and life sciences companies to help them realise their vision for the future of healthcare.
